Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages
B-cell chronic lymphocytic leukemia (B-CLL) is characterized by highly heterogeneous genomic alterations and altered signaling pathways, with limited studies on its proteome. Our study presents a comprehensive analysis of the proteome and phosphoproteome in B-CLL and CLL-like monoclonal B-cell lymph...
| Autores: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Recursos: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:dnet:digitalcsic_::3616416e584b10c2386608c20ac00e5a |
| Acesso em linha: | http://hdl.handle.net/10261/427616 https://api.elsevier.com/content/abstract/scopus_id/105000856819 |
| Access Level: | acceso abierto |
| Palavra-chave: | B-cell chronic lymphocytic leukemia BCR signaling Intracellular protein network Phosphoproteome Proteomics Tyrosine kinase |
| id |
ES_54fbbb2d4f22fa4cd03f66932aeb168b |
|---|---|
| oai_identifier_str |
oai:dnet:digitalcsic_::3616416e584b10c2386608c20ac00e5a |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stagesDíez, PaulaJuanes-Velasco, PabloGarcía-Vaquero, Marina L.Droste, ConradLandeira-Viñuela, AliciaAlcoceba, MiguelFidalgo-Gómez, HelenaMisiego-Herrero, SaraNavarro-Bailón, AlmudenaBaile, MónicaBastida, José MaríaSánchez-Santos, José ManuelGóngora, RafaelAlmeida, JuliaGonzález-Díaz, MarcosOrfao, AlbertoDe Las Rivas, JavierFuentes, ManuelB-cell chronic lymphocytic leukemiaBCR signalingIntracellular protein networkPhosphoproteomeProteomicsTyrosine kinaseB-cell chronic lymphocytic leukemia (B-CLL) is characterized by highly heterogeneous genomic alterations and altered signaling pathways, with limited studies on its proteome. Our study presents a comprehensive analysis of the proteome and phosphoproteome in B-CLL and CLL-like monoclonal B-cell lymphocytosis (MBL) primary cells. Using high-resolution mass spectrometry, we identified 2970 proteins and 316 phosphoproteins across five tumor samples, including 55 newly identified phosphopeptides (ProteomeXchange-PXD005997). Our multifaceted approach also integrated protein microarrays and western blotting for further data validation in a new patient cohort of 14 patients. Despite sharing 73% of their proteomes, the phosphoproteomes varied significantly among samples, independent of cytogenetic alterations and immunoglobulin heavy variable cluster (IGHV) mutational status. We identified common functional hallmarks in B-CLL and MBL phosphoproteomes, notably tonic signaling (low-level, constitutive signaling) of the B-cell antigen-specific receptor (BCR) and nuclear factor NF-kappa-B (NF-kβ)/signal transducer and activator of transcription 3 (STAT3) pathways. Nine phosphoproteins involved in BCR signaling were further validated, showing a high correlation with early disease stages. Our study advances the field by providing a detailed perspective on the proteome and phosphoproteome of B-CLL cells, revealing signaling pathways crucial for disease development and progression. Integrating diverse proteomics techniques and identifying novel phosphopeptides offers new insights into CLL biology, potentially informing future therapeutic strategies and biomarker development for early diagnosis and personalized treatment.We gratefully acknowledge financial support from the Spanish Health Institute Carlos III (ISCIII) for the grants FIS PI21/01545, FIS PI17/01930, CB16/12/00400. We also acknowledge Fondos FEDER (EU), Junta Castilla-León (COVID19 grant COV20EDU/00187) and Fundación Solórzano (FS23/2015). The Proteomics Unit belongs to ProteoRed, PRB3-ISCIII, supported by grant PT17 0019 0023, of the PE I + D + I 2017–2020, funded by ISCIII and FEDER. PD and CD are supported by a JCYL-EDU/346/2013 Ph.D. scholarship. AL-V is supported by VII Centenario-USAL PhD program. PJ-V is supported by JCYL PhD Program ‘Nos Impulsa-JCYL’ and scholarship JCYL-EDU/601/2020.Peer reviewedJohn Wiley & SonsInstituto de Salud Carlos IIIEuropean CommissionJunta de Castilla y LeónFundación Memoria de D. Samuel Solorzano BarrusoUniversidad de SalamancaConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202620262025info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10261/427616https://api.elsevier.com/content/abstract/scopus_id/105000856819reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)InglésThe underlying dataset has been published as supplementary material of the article in the publisher platform at DOI https://doi.org/10.1002/1878-0261.70032https://doi.org/10.1002/1878-0261.70032Síinfo:eu-repo/semantics/openAccessoai:dnet:digitalcsic_::3616416e584b10c2386608c20ac00e5a2026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages |
| title |
Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages |
| spellingShingle |
Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages Díez, Paula B-cell chronic lymphocytic leukemia BCR signaling Intracellular protein network Phosphoproteome Proteomics Tyrosine kinase |
| title_short |
Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages |
| title_full |
Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages |
| title_fullStr |
Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages |
| title_full_unstemmed |
Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages |
| title_sort |
Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages |
| dc.creator.none.fl_str_mv |
Díez, Paula Juanes-Velasco, Pablo García-Vaquero, Marina L. Droste, Conrad Landeira-Viñuela, Alicia Alcoceba, Miguel Fidalgo-Gómez, Helena Misiego-Herrero, Sara Navarro-Bailón, Almudena Baile, Mónica Bastida, José María Sánchez-Santos, José Manuel Góngora, Rafael Almeida, Julia González-Díaz, Marcos Orfao, Alberto De Las Rivas, Javier Fuentes, Manuel |
| author |
Díez, Paula |
| author_facet |
Díez, Paula Juanes-Velasco, Pablo García-Vaquero, Marina L. Droste, Conrad Landeira-Viñuela, Alicia Alcoceba, Miguel Fidalgo-Gómez, Helena Misiego-Herrero, Sara Navarro-Bailón, Almudena Baile, Mónica Bastida, José María Sánchez-Santos, José Manuel Góngora, Rafael Almeida, Julia González-Díaz, Marcos Orfao, Alberto De Las Rivas, Javier Fuentes, Manuel |
| author_role |
author |
| author2 |
Juanes-Velasco, Pablo García-Vaquero, Marina L. Droste, Conrad Landeira-Viñuela, Alicia Alcoceba, Miguel Fidalgo-Gómez, Helena Misiego-Herrero, Sara Navarro-Bailón, Almudena Baile, Mónica Bastida, José María Sánchez-Santos, José Manuel Góngora, Rafael Almeida, Julia González-Díaz, Marcos Orfao, Alberto De Las Rivas, Javier Fuentes, Manuel |
| author2_role |
author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Instituto de Salud Carlos III European Commission Junta de Castilla y León Fundación Memoria de D. Samuel Solorzano Barruso Universidad de Salamanca Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
B-cell chronic lymphocytic leukemia BCR signaling Intracellular protein network Phosphoproteome Proteomics Tyrosine kinase |
| topic |
B-cell chronic lymphocytic leukemia BCR signaling Intracellular protein network Phosphoproteome Proteomics Tyrosine kinase |
| description |
B-cell chronic lymphocytic leukemia (B-CLL) is characterized by highly heterogeneous genomic alterations and altered signaling pathways, with limited studies on its proteome. Our study presents a comprehensive analysis of the proteome and phosphoproteome in B-CLL and CLL-like monoclonal B-cell lymphocytosis (MBL) primary cells. Using high-resolution mass spectrometry, we identified 2970 proteins and 316 phosphoproteins across five tumor samples, including 55 newly identified phosphopeptides (ProteomeXchange-PXD005997). Our multifaceted approach also integrated protein microarrays and western blotting for further data validation in a new patient cohort of 14 patients. Despite sharing 73% of their proteomes, the phosphoproteomes varied significantly among samples, independent of cytogenetic alterations and immunoglobulin heavy variable cluster (IGHV) mutational status. We identified common functional hallmarks in B-CLL and MBL phosphoproteomes, notably tonic signaling (low-level, constitutive signaling) of the B-cell antigen-specific receptor (BCR) and nuclear factor NF-kappa-B (NF-kβ)/signal transducer and activator of transcription 3 (STAT3) pathways. Nine phosphoproteins involved in BCR signaling were further validated, showing a high correlation with early disease stages. Our study advances the field by providing a detailed perspective on the proteome and phosphoproteome of B-CLL cells, revealing signaling pathways crucial for disease development and progression. Integrating diverse proteomics techniques and identifying novel phosphopeptides offers new insights into CLL biology, potentially informing future therapeutic strategies and biomarker development for early diagnosis and personalized treatment. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 2026 2026 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/427616 https://api.elsevier.com/content/abstract/scopus_id/105000856819 |
| url |
http://hdl.handle.net/10261/427616 https://api.elsevier.com/content/abstract/scopus_id/105000856819 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
The underlying dataset has been published as supplementary material of the article in the publisher platform at DOI https://doi.org/10.1002/1878-0261.70032 https://doi.org/10.1002/1878-0261.70032 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
John Wiley & Sons |
| publisher.none.fl_str_mv |
John Wiley & Sons |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869408230608732160 |
| score |
15,81155 |